Senores Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs |

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Senores Pharmaceutic

DeciZen not available for IPO

10 Year X-Ray of Senores Pharmaceutic:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24TTM
ROCE % 2.9%5.5%2.6%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 13.512.4340
Sales YoY Gr.--8.6%174.7%-
Adj EPS 0.6-1.20.10
YoY Gr.--314%NA-
BVPS (₹) 38.539.755.10
Adj Net
Profit
0.5-1.20.4NAN
Cash Flow from Ops. -24.1-43.4-62.8-
Debt/CF from Ops. -0.6-1.4-1.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA174.7%
Adj EPS NANANANA
BVPSNANANA39%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24TTM
Return on
Equity %
1.5-3.30.40
Op. Profit
Mgn %
8.5-14.4-0.2NAN
Net Profit
Mgn %
3.7-9.71.1NAN
Debt to
Equity
0.41.60.6-
Working Cap
Days
01,7831,2620
Cash Conv.
Cycle
03111570

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Senores Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹.) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Management X-Ray of Senores Pharmaceutic:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Senores Pharmaceutic

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Sales13.5412.3834.01
Operating Expenses 12.3914.1634.07
Manufacturing Costs00.021.30
Material Costs8.205.8719.34
Employee Cost 2.865.029.35
Other Costs 1.323.254.07
Operating Profit 1.16-1.78-0.06
Operating Profit Margin (%) 8.5%-14.4%-0.2%
Other Income 0.946.796.85
Interest 0.562.142.71
Depreciation 0.710.932.04
Exceptional Items 000
Profit Before Tax 0.831.942.04
Tax 0.150.741.22
Profit After Tax 0.681.200.81
PAT Margin (%) 5.0%9.7%2.4%
Adjusted EPS (₹)0.81.20.3
Dividend Payout Ratio (%)0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 33.6938.92168.12
Share Capital 8.749.8230.51
Reserves 24.9529.11137.61
Minority Interest000
Debt14.2132.1727.79
Long Term Debt12.2224.1719.88
Short Term Debt1.998.017.91
Trade Payables6.054.3911.63
Others Liabilities 0.7736.0578.12
Total Liabilities 54.72111.54285.65

Fixed Assets

Gross Block2.879.9828.33
Accumulated Depreciation1.282.214.25
Net Fixed Assets1.597.7724.09
CWIP 3.1711.3318.47
Investments 11.698.2381.58
Inventories2.983.124.52
Trade Receivables8.3715.7322.01
Cash Equivalents 1.410.0910.44
Others Assets25.5065.26124.55
Total Assets 54.72111.54285.65

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Cash Flow From Operating Activity -24.06-43.41-62.82
PBT 0.831.942.04
Adjustment 0.60-1.57-2.59
Changes in Working Capital -25.35-43.32-61.07
Tax Paid -0.14-0.47-1.19
Cash Flow From Investing Activity -10.05-5.23-13.51
Capex -0.49-8.38-19.26
Net Investments 000
Others -9.573.155.75
Cash Flow From Financing Activity 33.8847.0886.68
Net Proceeds from Shares 24.022.6836.99
Net Proceeds from Borrowing 8.9913.2115.71
Interest Paid -0.56-1.84-2.55
Dividend Paid 000
Others 1.4233.0236.51
Net Cash Flow -0.23-1.5710.35
PARTICULARSMar'22Mar'23Mar'24
Ratios
ROE (%)2.023.30.79
ROCE (%)2.95.542.64
Asset Turnover Ratio0.250.150.17
PAT to CFO Conversion(x)-35.38-36.18-77.56
Working Capital Days
Receivable Days226355203
Inventory Days809041
Payable Days269325151

Senores Pharmaceuticals Ltd Stock News

Senores Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Senores Pharmaceutic on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Senores Pharmaceutic stood at ₹0.00.
The latest P/E ratio of Senores Pharmaceutic as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Senores Pharmaceutic as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Senores Pharmaceutic is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Senores Pharmaceutic is ₹0.00 ( Cr.) .

About Senores Pharmaceuticals Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.